The Bim up-regulation was required in the synergy of lenalidomide and NPI-0052 in MM [33], as well as in the contributing effect of NVP-Bez235 and HDAC inhibitor in DLBCL [27]. The gene discussed is BCL2L11; the disease is Miyoshi myopathy.